Silverlake Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Silverlake Wealth Management's AMGN Position: Q2 2026 in Review
Silverlake Wealth Management reduced its Amgen (AMGN) stake by 3.2% in Q2 2026, selling an estimated $49.6K and leaving 4,333 shares worth $1.57M. The position accounts for 0.3% of the portfolio, ranked #104.
Silverlake Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.65M in Q3 2023. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Silverlake Wealth Management held 4,333 shares of Amgen worth $1.57M as of Q2 2026.
- Silverlake Wealth Management sold 145 Amgen shares in Q2 2026, an estimated $49.6K.
- Amgen made up 0.3% of Silverlake Wealth Management's portfolio in Q2 2026, its #104 holding.
- Silverlake Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Silverlake Wealth Management's Amgen position peaked at $1.65M in Q3 2023.
- 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.